| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| DICE Therapeutics, Inc. | CMO | Common Stock | 0 | $46.50 | 09 Aug 2023 | Direct | |
| DICE Therapeutics, Inc. | CMO | Restricted Stock Units | 0 | 09 Aug 2023 | Direct | ||
| DICE Therapeutics, Inc. | CMO | Stock Option (right to buy) | 0 | 09 Aug 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919123045173-timothy-lu-2023-08-09 | DICE Therapeutics, Inc. | 09 Aug 2023 | 7 | $0 | 4 | CMO | 09 Aug 2023, 16:26 |
| /report/000120919123027782-timothy-lu-2023-05-03 | DICE Therapeutics, Inc. | 03 May 2023 | 1 | -$365,398 | 4 | CMO | 05 May 2023, 17:10 |
| /report/000120919123005772-timothy-lu-2023-01-27 | DICE Therapeutics, Inc. | 27 Jan 2023 | 2 | $0 | 4 | CMO | 31 Jan 2023, 16:37 |
| /report/000120919122024833-timothy-lu-2022-04-14 | DICE Therapeutics, Inc. | 14 Apr 2022 | 1 | $0 | 4 | CMO | 19 Apr 2022, 19:00 |
| /report/000120919121056523-timothy-lu-2021-09-14 | DICE Therapeutics, Inc. | 14 Sep 2021 | 4 | $0 | 4 | CMO | 16 Sep 2021, 21:24 |
| /report/000120919121056040-timothy-lu-2021-09-14 | DICE Therapeutics, Inc. | 14 Sep 2021 | 0 | $0 | 3 | CMO | 14 Sep 2021, 19:20 |